A 65-year-old Caucasian male with a 14-year history of diabetes returned to the primary care clinic for follow-up with the pharmacist regarding his type 2 diabetes. His last A1C was 8.1%.A month ago, the patient was changed from insulin aspart pen to liraglutide pen (0.6 mg daily) due to repeated challenges with the timing of the insulin aspart administration in relation to his meals. His other diabetes medications are metformin 1000 mg po BID and insulin glargine pen 36 units daily. He regularly visits his diabetes